Stifel Financial Corp Biomarin Pharmaceutical Inc Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Stifel Financial Corp holds 30,537 shares of BMRN stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,537
Previous 44,024 30.64%
Holding current value
$2.03 Million
Previous $3.62 Million 40.78%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $930,872 - $1.27 Million
-13,487 Reduced 30.64%
30,537 $2.15 Million
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $9,229 - $11,435
124 Added 0.28%
44,024 $3.62 Million
Q1 2024

May 13, 2024
SELL
$83.81 - $99.0 $484,086 - $571,824
-5,776 Reduced 11.63%
43,900 $3.83 Million
Q4 2023

Feb 12, 2024
BUY
$76.22 - $98.51 $340,550 - $440,142
4,468 Added 9.88%
49,676 $4.79 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $599,148 - $665,422
7,043 Added 18.45%
45,208 $4 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $75,064 - $86,859
-866 Reduced 2.22%
38,165 $3.31 Million
Q1 2023

May 12, 2023
SELL
$87.74 - $117.27 $404,393 - $540,497
-4,609 Reduced 10.56%
39,031 $3.8 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $135,072 - $181,303
1,669 Added 3.98%
43,640 $4.52 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $205,892 - $242,931
2,506 Added 6.35%
41,971 $3.56 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $466,549 - $566,869
-6,527 Reduced 14.19%
39,465 $3.27 Million
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $6.26 Million - $7.81 Million
-84,284 Reduced 64.7%
45,992 $3.55 Million
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $670,653 - $855,335
-9,351 Reduced 6.7%
130,276 $11.5 Million
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $1.72 Million - $1.96 Million
-22,967 Reduced 14.13%
139,627 $10.8 Million
Q2 2021

Aug 13, 2021
SELL
$75.51 - $84.79 $14,950 - $16,788
-198 Reduced 0.12%
162,594 $13.6 Million
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $1.07 Million - $1.3 Million
-14,313 Reduced 8.08%
162,792 $12.3 Million
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $555,103 - $689,579
7,645 Added 4.51%
177,105 $15.5 Million
Q3 2020

Nov 16, 2020
BUY
$71.87 - $131.03 $1.36 Million - $2.47 Million
18,870 Added 12.53%
169,460 $12.9 Million
Q2 2020

Aug 14, 2020
SELL
$79.55 - $124.22 $571,407 - $892,272
-7,183 Reduced 4.55%
150,590 $18.6 Million
Q1 2020

May 14, 2020
BUY
$71.37 - $96.85 $2.34 Million - $3.18 Million
32,824 Added 26.27%
157,773 $13.6 Million
Q4 2019

Feb 13, 2020
BUY
$64.27 - $86.37 $224,302 - $301,431
3,490 Added 2.87%
124,949 $10.8 Million
Q3 2019

Nov 19, 2019
SELL
$67.4 - $85.11 $7,481 - $9,447
-111 Reduced 0.09%
121,459 $8.25 Million
Q3 2019

Nov 13, 2019
BUY
$67.4 - $85.11 $1.38 Million - $1.74 Million
20,463 Added 20.24%
121,570 $8.26 Million
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $2.47 Million - $2.89 Million
30,735 Added 43.68%
101,107 $8.82 Million
Q1 2019

May 14, 2019
BUY
$84.2 - $98.62 $2.11 Million - $2.47 Million
25,012 Added 55.14%
70,372 $6.36 Million
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $406,790 - $538,411
5,076 Added 12.6%
45,360 $3.95 Million
Q3 2018

Nov 13, 2018
BUY
$93.92 - $105.72 $438,230 - $493,289
4,666 Added 13.1%
40,284 $3.89 Million
Q2 2018

Aug 14, 2018
BUY
$76.01 - $99.03 $1.99 Million - $2.59 Million
26,197 Added 278.07%
35,618 $3.35 Million
Q1 2018

May 11, 2018
BUY
$77.67 - $92.63 $396,350 - $472,690
5,103 Added 118.18%
9,421 $755,000
Q4 2017

Feb 14, 2018
SELL
$80.76 - $95.13 $58,954 - $69,444
-730 Reduced 14.46%
4,318 $382,000
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $406,868 - $479,307
5,048
5,048 $0

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email